Kazia Therapeutics Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q3 24 | Q4 24 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2,561.0% | -92.5% | +2,250.6% | -96.1% | +2,671.8% | -92.8% | +1,842.7% | -54.2% | +327.5% | -53.2% | -65.5% | -46.4% | -93.2% | +2,837.1% | -50.6% | -56.3% | -95.6% | +4,408.1% | -6.9% | -71.0% | -5,536.4% | – | -99.7% | +648,683.8% | – | – | -99.9% | – | – | – | – | – | – | – | -99.5% | +49,619,800.0% | -99.1% | -11.6% | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,561.0% | -92.5% | +2,250.6% | -96.1% | +2,671.8% | -269.5% | – | -54.2% | +327.5% | -162.9% | – | -46.4% | -60.4% | -2,793.5% | – | -56.3% | -95.6% | -61,701.2% | – | -71.0% | -5,536.4% | – | -99.7% | +648,683.8% | – | – | -99.9% | – | – | – | – | – | – | – | -99.5% | +49,619,800.0% | -99.1% | -11.6% | – | |
| – | +78.4% | +12.1% | +50.0% | -51.3% | +51.6% | +31.9% | 0.0% | -35.9% | +60.5% | +24.6% | -24.9% | -45.9% | -60.4% | +405.5% | -27.0% | -62.7% | -96.1% | +5,078.8% | +51.6% | -36.8% | -100.0% | +547,310.7% | -46.0% | +104.3% | – | – | -5.9% | -58.2% | +2.0% | +96.2% | +2.0% | -66.9% | – | – | -30.2% | +201.6% | -67.2% | -31.0% | +65.8% | |
| – | +240.6% | -41.3% | +32.2% | -56.5% | +309.2% | -51.1% | +48.1% | -42.6% | +224.8% | -38.4% | -2.3% | -87.2% | +213.8% | -36.3% | +82.7% | -59.3% | +345.6% | -55.1% | +23.9% | -62.3% | – | – | +125.6% | -51.8% | – | – | -28.0% | -47.0% | +62.5% | +23.0% | +62.5% | -49.6% | – | – | +5.8% | +97.7% | -43.3% | – | – | |
| – | +291.4% | -48.9% | +37.6% | -37.7% | +265.5% | -45.3% | +3.2% | -38.7% | +251.9% | -43.2% | -89.2% | +250.1% | -100.0% | +4,707,490.5% | -15.1% | -62.8% | -96.7% | +5,919.8% | +22.0% | -43.4% | -383.0% | – | -6.5% | +36.6% | – | – | -11.0% | -56.0% | +15.7% | +270.0% | -46.3% | -74.2% | – | – | -15.5% | +148.3% | -57.4% | -31.2% | +105.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -116.6% | – | – | – | – | -25,280.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -18.9% | +23.4% | -99.5% | -100.0% | – | +12,571.7% | -93.9% | -50.0% | +100.0% | +1,552.8% | -100.0% | – | -60.4% | +32,837.2% | -100.0% | – | – | – | -100.0% | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -1,278.7% | – | – | – | – | – | – | – | – | – | -214.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | -100.2% | – | – | – | – | – | -346.1% | – | – | – | -139.6% | – | – | – | -200.1% | – | – | – | -200.0% | – | – | – | -200.0% | – | – | – | +160.1% | -176.9% | – | – | -200.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -860.9% | – | – | – | – | – | – | – | – | – | -142.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -115.2% | – | – | – | – | -1,706.5% | – | – | – | – | – | – | – | – | – | – | – | – |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.